Jeffrey S. Lorberbaum, a director of Mohawk Industries Inc, filed a Form 144 notice on November 3, 2026, proposing the sale of 1,646 shares of Mohawk Industries common stock through broker TD Securities (USA) LLC on the New York Stock Exchange.
Sarah Elizabeth Schubach, Chief Accounting Officer of Dropbox, Inc., filed a Form 4 on November 3, 2026, reporting the sale of 2,055 shares of Class A Common Stock on October 30, 2026.
nCino, Inc. officer April Rieger filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 8,008 shares of nCino common stock with an aggregate market value of $182,019.44, to be executed through Fidelity Brokerage Services LLC on NASDAQ.
Century Therapeutics, Inc. officer Douglas Carr filed a Form 144 notice on November 3, 2026, proposing to sell 266 shares of Century Therapeutics common stock on NASDAQ, with an aggregate market value of $403.94.
Director Ronald K. Grubbs Jr. filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of common stock and phantom stock units in UFP Industries Inc on November 2, 2026.
Patrick John Finn, an officer of Twist Bioscience Corp, filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 2,565 shares of common stock on NASDAQ:TWST.
Henry Schein, Inc. filed its Form 10-Q for the quarterly period ended September 26, 2026, with the SEC on November 3, 2026, reporting third-quarter net sales of $3.471 billion and net income attributable to the company of $119 million.
The Bank of Nova Scotia filed a free writing prospectus on November 3, 2026, under Rule 433 and Registration Statement No. 333-298611, disclosing terms for Autocallable Strategic Accelerated Redemption Securities linked to the S&P 500 Index.
ExxonMobil Holdings Corporation filed Amendment No. 29 to its Schedule 13G with the SEC on November 3, 2026, disclosing its beneficial ownership position in Imperial Oil Ltd as of September 30, 2026.
Robert F. Werner, an officer of Twist Bioscience Corp, filed a Form 144 notice of proposed sale on November 3, 2026, covering 148 shares of common stock with an aggregate market value of $20,039.45.